People
Ann Boija
Dewpoint chief scientific officer leading condensate-based research across oncology, neurology, cardiology and metabolic disease. Her work studies gene control, transcription factor phase separation and drug partitioning into condensates. Holds a Stockholm University biology PhD and trained at the Whitehead Institute.
Roles
Dewpoint Therapeutics
CurrentChief Scientific Officer